ProstaLund AB (publ) (STO:PLUN)

Market Cap	1.54M
Revenue (ttm)	13.97M
Net Income (ttm)	-22.91M
Shares Out	3.62M
EPS (ttm)	-6.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	910
Average Volume	166,360
Open	0.4080
Previous Close	0.4620
Day's Range	0.4080 - 0.4560
52-Week Range	0.3920 - 22.2400
Beta	0.14
RSI	28.31
Earnings Date	Jul 14, 2025

About ProstaLund AB

rostaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally market drugs. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsid...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1991
• Employees: 9
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PLUN

Financial Performance

In 2024, ProstaLund AB's revenue was 13.73 million, a decrease of -37.79% compared to the previous year's 22.06 million. Losses were -22.63 million, 33.0% more than in 2023.